Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Robert V. Zupkis"'
Autor:
Carlos A. Dujovne, Michael H. Davidson, Michael R. Dobrinska, Evan A. Stein, Stuart R. Weiss, Robert H. Knopp, Robert V. Zupkis, Jonathan A. Tobert, Donald B. Hunninghake, D. Roger Illingworth, Yale B. Mitchel, Raju D. Amin, Michael Melino
Publikováno v:
The American Journal of Cardiology. 79:38-42
The hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin is the most effective of the currently approved hypolipidemic drugs and has been shown to reduce mortality and coronary morbidity in patients with coronary artery disease. For these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::771d783123a921461769e189d05a8793
https://doi.org/10.1016/s0002-9149(96)00742-4
https://doi.org/10.1016/s0002-9149(96)00742-4
Autor:
Malcolm G. Baines, Robert V. Zupkis, Alan Vost, Ruth McPherson, Hugh F. Pross, Chris Tsoukas, Michael Melino
Publikováno v:
Journal of clinical immunology. 13(6)
Suppression of cholesterol synthesis by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, such as lovastatin, has been shown to inhibit mitogen stimulated proliferation of natural killer (NK) cells and other lymphocytes in vitro.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7eb155c752cc3caabd6c200ae45868
https://pubmed.ncbi.nlm.nih.gov/8288727
https://pubmed.ncbi.nlm.nih.gov/8288727
Publikováno v:
Clinical pharmacology and therapeutics. 48(4)
Patients with non–insulin dependent diabetes mellitus (NIDDM) have a higher risk of atherosclerotic cardiovascular disease than nondiabetic subjects. In seven patients with both hypercholesterolemia and NIDDM controlled by chlorpropamide, lovastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0216279422416c7288a99c8288b0c113
https://pubmed.ncbi.nlm.nih.gov/2225707
https://pubmed.ncbi.nlm.nih.gov/2225707
Autor:
Robert H. Knopp, Carlos A. Dujovne, Yale B. Mitchel, P. Tun, R. A. Greguski, Philip H. Frost, Evan A. Stein, Robert V. Zupkis, D.R. Illingworth
Publikováno v:
Archives of Internal Medicine. 154:1586
Background: Niacin and lovastatin are both effective drugs for the treatment of hypercholesterolemia and are among the drugs of first choice recommended by the adult treatment panel. To date, however, no studies have directly compared the lipoprotein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c67814db1d0fd455aa03b83078ad8ea
https://doi.org/10.1001/archinte.1994.00420140051007
https://doi.org/10.1001/archinte.1994.00420140051007
Publikováno v:
Scandinavian journal of psychology. 28(3)
Improvement in quality of life (QL) is a primary objective of medical care, and the natural consequence of efforts made in hospital or during convalescence. Pharmacological intervention usually gives relief of symptoms, but may introduce expected and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8df50fee02f80e4890c505f97de134
https://pubmed.ncbi.nlm.nih.gov/3441769
https://pubmed.ncbi.nlm.nih.gov/3441769
Publikováno v:
The New England journal of medicine. 302(16)
We explored reasons for the failure of patients to recall major portions of the information on consent forms and in oral explanations about consent. Within one day of signing consent forms for chemotherapy, radiation therapy, or surgery, 200 cancer p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67a421717006652b77e343becac48656
https://pubmed.ncbi.nlm.nih.gov/7360175
https://pubmed.ncbi.nlm.nih.gov/7360175
Publikováno v:
Clinical pharmacology and therapeutics. 37(2)
The antiarrhythmic effect of timolol was investigated in 160 subjects with supraventricular arrhythmias. In our double-blind, randomized, parallel, multiclinic study, subjects received timolol, 1 mg iv, or matching placebo as a starting dose, followe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3aac622214105fd6e84b3f828adc1cb
https://pubmed.ncbi.nlm.nih.gov/3881206
https://pubmed.ncbi.nlm.nih.gov/3881206
Publikováno v:
Annals of internal medicine. 92(6)
The present study explored the degree to which patients prefer to become informed about and to participate in their medical care. A total of 256 cancer patients completed an Information Styles Questionnaire and the Beck Hopelessness Scale. Patients'
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80d556e40289649c2067b1aa038c9d0
https://pubmed.ncbi.nlm.nih.gov/7387025
https://pubmed.ncbi.nlm.nih.gov/7387025